Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI).
Caplice NM, DeVoe MC, Choi J, Dahly D, Murphy T, Spitzer E, Van Geuns R, Maher MM, Tuite D, Kerins DM, Ali MT, Kalyar I, Fahy EF, Khider W, Kelly P, Kearney PP, Curtin RJ, O'Shea C, Vaughan CJ, Eustace JA, McFadden EP.
Caplice NM, et al.
Am Heart J. 2018 Jun;200:110-117. doi: 10.1016/j.ahj.2018.03.018. Epub 2018 Apr 3.
Am Heart J. 2018.
PMID: 29898838
Clinical Trial.